Quanterix's (QTRX) Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples

Go back to Quanterix's (QTRX) Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples

Quanterix’ Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples

March 26, 2021 6:47 AM EDT

Companys SARS-CoV-2 N-Protein Assay measures viral antigen in plasma, dried blood spots and saliva in more than 90 percent of COVID-19 PCR+ positive donors, including those without symptoms

BILLERICA, Mass.--(BUSINESS WIRE)--

Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision... More